Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

The importance of the neutrophil-to-lymphocyte ratio in the prognosis of glioma and its subtypes.

Linhares P, Ferreira A, Vaz R.

CNS Neurosci Ther. 2019 Nov 15. doi: 10.1111/cns.13270. [Epub ahead of print] No abstract available.

PMID:
31733020
2.

Preoperative neutrophil-lymphocyte ratio correlated with glioma grading and glioblastoma survival.

Weng W, Chen X, Gong S, Guo L, Zhang X.

Neurol Res. 2018 Nov;40(11):917-922. doi: 10.1080/01616412.2018.1497271. Epub 2018 Aug 3.

PMID:
30074469
3.

Prognostic significance of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioma.

Wang J, Xiao W, Chen W, Hu Y.

EXCLI J. 2018 May 28;17:505-512. doi: 10.17179/excli2017-978. eCollection 2018.

4.

Prognostic role of neutrophil lymphocyte ratio in patients with glioma.

Zhang J, Zhang S, Song Y, He M, Ren Q, Chen C, Liu Z, Zeng Y, Xu J.

Oncotarget. 2017 Jul 22;8(35):59217-59224. doi: 10.18632/oncotarget.19484. eCollection 2017 Aug 29.

5.

Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival.

Wiencke JK, Koestler DC, Salas LA, Wiemels JL, Roy RP, Hansen HM, Rice T, McCoy LS, Bracci PM, Molinaro AM, Kelsey KT, Wrensch MR, Christensen BC.

Clin Epigenetics. 2017 Feb 2;9:10. doi: 10.1186/s13148-017-0316-8. eCollection 2017.

6.

Peripheral blood test provides a practical method for glioma evaluation and prognosis prediction.

Wang ZL, Zhang CB, Liu YQ, Wang Z, Jiang T.

CNS Neurosci Ther. 2019 Aug;25(8):876-883. doi: 10.1111/cns.13120. Epub 2019 Mar 26.

7.

Relationship of preoperative neutrophil lymphocyte ratio with prognosis in gastrointestinal stromal tumors.

Kargın S, Çakır M, Gündeş E, Yavuz Y, Esen HH, Sinan İyisoy M, Kökbudak N, Küçükkartallar T.

Ulus Cerrahi Derg. 2015 Jun 1;31(2):61-4. doi: 10.5152/UCD.2015.2840. eCollection 2015.

8.

Risk stratification with longitudinal neutrophil to lymphocyte ratio assessment after left ventricular assist device implantation.

Bhat G, Yost GL, Ibrahim K, Pappas P, Tatooles A.

Int J Artif Organs. 2018 Aug;41(8):445-451. doi: 10.1177/0391398818784276. Epub 2018 Jul 5.

PMID:
29976125
9.

Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.

Zheng SH, Huang JL, Chen M, Wang BL, Ou QS, Huang SY.

J Neurosurg. 2018 Sep;129(3):583-592. doi: 10.3171/2017.3.JNS161648. Epub 2017 Nov 3.

PMID:
29099300
10.
11.

Pre-treatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy.

Zeng YC, Chi F, Xing R, Xue M, Wu LN, Tang MY, Wu R.

Jpn J Clin Oncol. 2016 Feb;46(2):126-31. doi: 10.1093/jjco/hyv175. Epub 2015 Nov 25.

12.

Preoperative Hematologic Inflammatory Markers as Prognostic Factors in Patients with Glioma.

Bao Y, Yang M, Jin C, Hou S, Shi B, Shi J, Lin N.

World Neurosurg. 2018 Nov;119:e710-e716. doi: 10.1016/j.wneu.2018.07.252. Epub 2018 Aug 6.

PMID:
30092479
13.

Neutrophil-lymphocyte ratios in the prognostication of primary non-metastatic nasopharyngeal carcinoma.

Liew KY, Zulkiflee AB.

Braz J Otorhinolaryngol. 2018 Nov - Dec;84(6):764-771. doi: 10.1016/j.bjorl.2017.09.004. Epub 2017 Oct 19.

14.

Positive correlation between sarcopenia and elevation of neutrophil/lymphocyte ratio in pathological stage IIIA (N2-positive) non-small cell lung cancer patients.

Tsukioka T, Izumi N, Mizuguchi S, Kyukwang C, Komatsu H, Toda M, Hara K, Miyamoto H, Nishiyama N.

Gen Thorac Cardiovasc Surg. 2018 Dec;66(12):716-722. doi: 10.1007/s11748-018-0985-z. Epub 2018 Aug 13. Erratum in: Gen Thorac Cardiovasc Surg. 2019 Mar;67(3):348.

PMID:
30105630
15.

Roles of white blood cells and subtypes as inflammatory markers in skin cancer.

Baykan H, Cihan YB, Ozyurt K.

Asian Pac J Cancer Prev. 2015;16(6):2303-6.

16.

Prognostic Role of Neutrophil to Lymphocyte Ratio in Ovarian Cancer: A Meta-Analysis.

Chen G, Zhu L, Yang Y, Long Y, Li X, Wang Y.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818791500. doi: 10.1177/1533033818791500.

17.

THE ROLE OF IMMUNOINFLAMMATORY MARKERS IN THE PROGNOSIS AND RESECTABILITY OF PANCREATIC ADENOCARCINOMA.

Eyff TF, Bosi HR, Toni MS, Zilio MB, Corso CO, Bersch VP, Osvaldt AB.

Arq Bras Cir Dig. 2018;31(2):e1366. doi: 10.1590/0102-672020180001e1366. Epub 2018 Jul 2. English, Portuguese.

18.

Followup of neutrophil-to-lymphocyte ratio and recurrence of clear cell renal cell carcinoma.

Ohno Y, Nakashima J, Ohori M, Gondo T, Hatano T, Tachibana M.

J Urol. 2012 Feb;187(2):411-7. doi: 10.1016/j.juro.2011.10.026. Epub 2011 Dec 15.

PMID:
22177153
19.

Prognostic impact of neutrophil-to-lymphocyte ratio in gliomas: a systematic review and meta-analysis.

Lei YY, Li YT, Hu QL, Wang J, Sui AX.

World J Surg Oncol. 2019 Aug 31;17(1):152. doi: 10.1186/s12957-019-1686-5. Review.

20.

The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.

Huszno J, Kolosza Z, Mrochem-Kwarciak J, Rutkowski T, Skladowski K.

Oncology. 2019;97(1):7-17. doi: 10.1159/000498943. Epub 2019 May 2.

PMID:
31048577

Supplemental Content

Support Center